Isaac Oved, founder and chief executive of the Oved Group, and Dr. Joseph Oved, president of the Oved Group’s investment portfolio in partnership with other launched New World Health, a venture capital firm with focus on investing in health and wellness companies.
Adam Henick, founder and former president of Mount Sinai Ambulatory Ventures, is using his health care investing expertise to launch a venture capital firm, New World Health. Henick is one of the Manhattan-based firm’s six managing partners, who have collectively invested $50 million to start the company. "After seven years of producing excellent returns on investment for both Continuum Health Partners and Mount Sinai, I determined it was time for me to go out on my own so I could have more capital to work with and the opportunity to do better for myself,” said Henick. New World Health will focus on investing in health and wellness companies, but Henick said that field will be loosely defined. The firm has invested in three companies so far: Salt Lake City, Utah–based Owlet, which manufactures a sock that allows parents to remotely monitor their infants’ vital signs; Epicured, a Manhattan-based meal delivery service catering to people with digestive illnesses; and San Carlos, Calif.– based BioTrace Medical, which has created a device to reduce complications in transcatheter aortic valve replacement surgery. New World Health’s other managing partners are Isaac Oved, founder and chief executive of the Oved Group, a Manhattan investing firm; Dr. Ronald Mizrahi, president of Mizrahi Orthodontics; Dr. Paul Low, who previously led a group physician practice; Dr. Edward Lung, associate professor of medicine and gastroenterology at the Icahn School of Medicine at Mount Sinai; and Dr. Joseph Oved, a physician in hematology/oncology and president of the Oved Group’s investment portfolio. —C.L.
Source: Crain's Health Pulse